1. A semiconductor device comprising:
a first bit line;
a second bit line;
a first redundant bit line;
a second redundant bit line;
a plurality of first word lines each crossing said first bit line;
a plurality of second word lines each crossing said second bit line, each of the second word lines being provided separately from each of the first word lines;
a plurality of first memory cells each disposed at a different one of intersections of said first bit line and said first word lines;
a plurality of second memory cells each disposed at a different one of intersections of said second bit line and said second word lines;
a plurality of first redundant memory cells connected to said first redundant bit line,
a plurality of second redundant memory cells connected to said second redundant bit lines;
a first amplifier circuit connected to said first bit line and said second bit line to amplify a difference in potential between said first bit line and said second bit line; and
a first redundant amplifier circuit connected to said first redundant bit line and said second redundant bit line to amplify a difference in potential between said first redundant bit line and said second redundant bit line,
wherein said semiconductor device is configured such that said first bit line is replaced with said first redundant bit line but said second bit line is not replaced with said second redundant bit line.
2. A semiconductor device comprising:
a first bit line;
a second bit line;
a third bit line;
a fourth bit line;
a first redundant bit line;
a second redundant bit line;
a plurality of first memory cells connected to said first bit line;
a plurality of second memory cells connected to said second bit line;
a plurality of third memory cells connected to said third bit line;
a plurality of fourth memory cells connected to said fourth bit line;
a plurality of first redundant memory cells connected to said first redundant bit line;
a plurality of second redundant memory cells connected to said second redundant bit line;
a first amplifier circuit connected to said first bit line and said second bit line to amplify a difference in potential between said first bit line and said second bit line;
a second amplifier circuit connected to said third bit line and said fourth bit line to amplify a difference in potential between said third bit line and said fourth bit line; and
a first redundant amplifier circuit connected to said first redundant bit line and said second redundant bit line to amplify a difference in potential between said first redundant bit line and said second redundant bit line,
wherein a defective cell among said first memory cells is replaced with one of said first redundant memory cells, and a defective cell among said fourth memory cells is replaced with one of said second redundant memory cells.
3. A semiconductor device according to claim 1, wherein the pluralities of first and second memory cells and the pluralities of first and second redundant memory cells are dynamic memory cells.
4. A semiconductor device according to claim 1, wherein the semiconductor device is logic LSI including memory cells.
5. A semiconductor memory circuit according to claim 2, wherein the pluralities of first and second memory cells and the pluralities of first and second redundant memory cells are dynamic memory cells.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A drug-delivery device, comprising:
a refillable reservoir having a self-resealing upper layer that is pierceable by a needle for refilling and an opposed lower layer that is unpuncturable by the needle so as to protect an eye from injury, and containing a liquid that comprises a therapeutic agent selected from the group consisting of acetazolamide, betaxolol, bevacizumab, bimatoprost, brimonidine, brinzolamide, carbidopa, carteolol, cidofovir, cyclosporine, dorzolamide, epinephrine, a growth factor, irinotecan, ketorolac tromethamine, ketotifen fumarate, latanoprost, levobetaxolol, levobunolol, levodopa, levofloxacin, loratadine, loteprednol etabonate, metipranolol, naphazoline, ofloxacin, pegaptanib, pemirolast, pheniramine maleate, pilocarpine, pseudoephedrine, ranibizumab, a steroid, timolol, travoprost, trifluridine, tumor necrosis factor blocker, unoprostone isopropyl, valganciclovir, verteporfin, vitravene, a drug that prevents beta amyloid deposition in the retina, a drug that prevents beta amyloid deposition in the brain, an anti-human complement activation blocker that blocks complement H activation in the eye, and siRNA molecules;
a cannula in fluid communication with the reservoir, the cannula having an outlet for delivering the therapeutic agent to a patient;
a memory for storing a drug-delivery regimen;
a microprocessor for executing the stored drug-delivery regimen; and
a sensor for detecting a position and an activity of the patient, the microprocessor determining at least one of a frequency, time, or dosage of the liquid delivered to the patient based thereon and responsively controlling delivery of the liquid.
2. The device of claim 1, wherein the device is shaped to conform to a curved contour of the eye.
3. The device of claim 1, wherein the lower layer is implanted adjacent to the sclera of the eye and the cannula is inserted into the eye through the sclera to facilitate delivery of drug from the reservoir into the eye.
4. The device of claim 1, further comprising a sensor for receiving feedback from the patient, the microprocessor being configured to modify the drug-delivery regimen based on the feedback.
5. The device of claim 1, further comprising a sensor for detecting a measured eye pressure for the patient.
6. The device of claim 5, wherein the sensor monitors physiological effects of the therapeutic agent present for determining a residual amount of the therapeutic agent in a tissue of the patient.
7. The device of claim 1, further comprising a transceiver for receiving wireless instructions that reprogram the drug-delivery regimen.
8. The device of claim 1, further comprising:
an electrolysis chamber including a gas-impermeable flexible membrane configured to expand and contract with increases and decreases in pressure in the electrolysis chamber, the flexible membrane also constituting a portion of the reservoir; and
at least two electrodes in the electrolysis chamber, the electrodes being responsive to the microprocessor to produce gas in the electrolysis chamber to expand the membrane and thereby force liquid from the reservoir through the cannula.
9. The device of claim 1, further comprising a valve disposed in the cannula, wherein the valve controls fluid delivery, maintains a constant flow rate independent of variations in pressure driving a fluid flow through the cannula, and prevents backflow.